BICYCLE THERAPEUTICS PLC's ticker is BCYC and the CUSIP is 088786108. A total of 106 filers reported holding BICYCLE THERAPEUTICS PLC in Q1 2022. The put-call ratio across all filers is 0.23 and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $126,487 | -24.1% | 6,296 | -3.6% | 0.00% | – |
| Q2 2023 | $166,697 | +32.4% | 6,532 | +10.4% | 0.00% | – |
| Q1 2023 | $125,897 | -22.8% | 5,919 | +7.4% | 0.00% | – |
| Q4 2022 | $163,184 | -23.0% | 5,513 | -39.6% | 0.00% | – |
| Q3 2022 | $212,000 | -26.9% | 9,126 | -47.2% | 0.00% | – |
| Q2 2022 | $290,000 | +113.2% | 17,297 | +456.2% | 0.00% | – |
| Q1 2022 | $136,000 | -11.1% | 3,110 | +23.2% | 0.00% | – |
| Q4 2021 | $153,000 | +70.0% | 2,524 | +17.1% | 0.00% | – |
| Q3 2021 | $90,000 | +26.8% | 2,156 | -7.5% | 0.00% | – |
| Q2 2021 | $71,000 | +129.0% | 2,332 | +119.4% | 0.00% | – |
| Q1 2021 | $31,000 | +675.0% | 1,063 | +392.1% | 0.00% | – |
| Q4 2020 | $4,000 | – | 216 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SV Health Investors, LLC | 917,218 | $40,248,000 | 48.61% |
| GREAT POINT PARTNERS LLC | 550,592 | $24,160,000 | 5.84% |
| Logos Global Management LP | 950,000 | $41,686,000 | 5.40% |
| Deep Track Capital, LP | 1,855,993 | $81,441,000 | 5.22% |
| First Light Asset Management, LLC | 890,174 | $39,061,000 | 3.44% |
| TYBOURNE CAPITAL MANAGEMENT (HK) LTD | 1,154,126 | $50,643,000 | 3.00% |
| Ikarian Capital, LLC | 478,784 | $21,009,000 | 2.76% |
| Opaleye Management Inc. | 175,000 | $7,679,000 | 2.38% |
| Frazier Life Sciences Management, L.P. | 603,521 | $26,483,000 | 2.26% |
| Altium Capital Management LP | 120,000 | $5,266,000 | 1.76% |